Cargando…

NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma

Lung adenocarcinoma (LUAD) is the most prevalent histologic type of lung cancer, associated with a high incidence rate and substantial mortality rate worldwide. Accumulating evidence shows that the aberrant expression of neuromedin U (NMU) contributes to the initiation and progression of cancer. Her...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yan, Hu, Chunsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292091/ https://www.ncbi.nlm.nih.gov/pubmed/34336003 http://dx.doi.org/10.1155/2021/5031479

Ejemplares similares

The YAP1–NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target
por: Yoo, Wonbeak, et al.
Publicado: (2019)

Neuromedins NMU and NMS: An Updated Overview of Their Functions
por: Malendowicz, Ludwik K., et al.
Publicado: (2021)

NMUR1 in the NMU-Mediated Regulation of Bone Remodeling
por: Hsiao, Yu-Tin, et al.
Publicado: (2021)

Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression
por: Zhang, Jia-Jia, et al.
Publicado: (2021)

Histological analysis of low dose NMU effects in the rat mammary gland
por: Murray, Tessa J, et al.
Publicado: (2009)

Peripheral Administration of NMU Promotes White Adipose Tissue Beiging and Improves Glucose Tolerance
por: Yuan, Yue, et al.
Publicado: (2021)

Expression of NMU, PPBP and GNG4 in colon cancer and their influences on prognosis
por: Chen, Danyu, et al.
Publicado: (2022)

Proceedings: Immunosuppressive activity of N-nitroso-N-methylurea (NMU) and dimethylnitrosamine (DMN).
por: Waynforth, H. B., et al.
Publicado: (1974)

NMU signaling promotes endometrial cancer cell progression by modulating adhesion signaling
por: Lin, Ting-Yu, et al.
Publicado: (2016)

Effectiveness of combined limonene and 4-hydroxyandrostenedione in the treatment of NMU-induced rat mammary tumours.
por: Chander, S. K., et al.
Publicado: (1994)

Evaluation of NMU-Induced Breast Cancer Treated with Sirolimus and Sunitinib on Breast Cancer Growth
por: Jaffar, Nurul Fathiyatul Nabila, et al.
Publicado: (2020)

Characterizing prescription stimulant nonmedical use (NMU) among adults recruited from Reddit
por: Vosburg, Suzanne K., et al.
Publicado: (2021)

Examining the Role of Hypothalamus-Derived Neuromedin-U (NMU) in Bone Remodeling of Rats
por: Born-Evers, Gabriella, et al.
Publicado: (2023)

Moniezia benedeni infection enhances neuromedin U (NMU) expression in sheep (Ovis aries) small intestine
por: Yao, Wan-Ling, et al.
Publicado: (2022)

Monitoring therapeutic response to tamoxifen in NMU-induced rat mammary tumours by 31P MRS.
por: Baluch, S., et al.
Publicado: (1991)

Neuroanatomical characterization of the Nmu-Cre knock-in mice reveals an interconnected network of unique neuropeptidergic cells
por: Medrano, Mireia, et al.
Publicado: (2023)

CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma
por: Yang, Yanlong, et al.
Publicado: (2021)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

High expression of forkhead box M1 (FOXM1) is a poor prognostic biomarker in lung adenocarcinoma
por: Xiao, Hong, et al.
Publicado: (2020)

Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma
por: Yuan, Yinjiao, et al.
Publicado: (2023)

Preventive effect of Oenothera rosea on N-methyl-N-nitrosourea-(NMU) induced gastric cancer in rats
por: Almora-Pinedo, Yuan, et al.
Publicado: (2017)

Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma
por: de Miguel-Pérez, Diego, et al.
Publicado: (2019)

The Role of Upregulated DDX11 as A Potential Prognostic and Diagnostic Biomarker in Lung Adenocarcinoma
por: Li, Jianhao, et al.
Publicado: (2019)

Overexpression of GSDMC is a prognostic factor for predicting a poor outcome in lung adenocarcinoma
por: Wei, Jie, et al.
Publicado: (2020)

Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma
por: Li, Tingting, et al.
Publicado: (2022)

ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
por: Zheng, Yu-Zhu, et al.
Publicado: (2016)

Comparative Study on The Preventive Effect of Saffron Carotenoids, Crocin and Crocetin, in NMU-Induced Breast Cancer in Rats
por: Sajjadi, Meysam, et al.
Publicado: (2017)

Protective effect of Chuquiraga spinosa extract on N-methyl-nitrosourea (NMU) induced prostate cancer in rats
por: Arroyo-Acevedo, Jorge, et al.
Publicado: (2017)

CHSY3 can be a Poor Prognostic Biomarker and Mediates Immune Evasion in Stomach Adenocarcinoma
por: Li, Xinwei, et al.
Publicado: (2022)

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
por: Yu, Yilin, et al.
Publicado: (2021)

The new silicone elastometric half-piece respirator, VJR-NMU: A novel and effective tool to prevent COVID-19
por: Manomaipiboon, Anan, et al.
Publicado: (2020)

Spondin2 is a new prognostic biomarker for lung adenocarcinoma
por: Yuan, Xiaopeng, et al.
Publicado: (2017)

Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis
por: Hou, Jili, et al.
Publicado: (2021)

The expression of plakoglobin is a potential prognostic biomarker for patients with surgically resected lung adenocarcinoma
por: He, Xiaobo, et al.
Publicado: (2016)

GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma
por: Song, Shimao, et al.
Publicado: (2022)

Overexpression of hsa_circ_0001715 is a Potential Diagnostic and Prognostic Biomarker in Lung Adenocarcinoma
por: Lu, Guo-jun, et al.
Publicado: (2020)

DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma
por: Wu, Yang-Jie, et al.
Publicado: (2021)

ERRα is an aggressive factor in lung adenocarcinoma indicating poor prognostic outcomes
por: Li, Ping, et al.
Publicado: (2019)

CHKA mediates the poor prognosis of lung adenocarcinoma and acts as a prognostic indicator
por: Zhang, Li, et al.
Publicado: (2016)

PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy
por: Du, Xingyi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6o9i6lfc1aa4q06ofttd1ph9of